The Effects on Physical Activity on Mitochondrial Function in Skin Fibroblasts in Patients with Parkinson's Disease.
PARKEX
1 other identifier
interventional
24
1 country
1
Brief Summary
The aim of this study is to investigate the effect of physical activity on mitochondrial function in skin fibroblasts in patients with Parkinson's disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2023
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 12, 2023
CompletedFirst Posted
Study publicly available on registry
July 27, 2023
CompletedStudy Start
First participant enrolled
September 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2026
CompletedFebruary 25, 2025
January 1, 2025
9 months
July 12, 2023
February 21, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change in oxygen consumption rate
Oxygen uptake (VO2, mlkg-1min-1) measured by Seahorse XFe96
Beginning of the study and after 4 months
Change in ATPmax levels
Maximal mitochondrial ATP production rates measured by Seahorse XFe96
Beginning of the study and after 4 months
Secondary Outcomes (10)
Non-motor and motor function
Beginning of the study, first visit
Sleepiness
Beginning of the study, first visit
Mobility
Beginning of the study, first visit
Cognitive aspects
Beginning of the study, first visit
Mood
Beginning of the study, first visit
- +5 more secondary outcomes
Study Arms (3)
Physical activity: basic physical training (BPT)
EXPERIMENTALExercises will target the large muscle groups, with a component/emphasis on the eccentric phase of concentration. The kBox4 Platform (Exxentric AB), a device designed to maximize performance and training outcomes, will be used to enhance the eccentric phase of the exercises. kBox4 is controlled by a specific program, Kmeter, which records and stores all the information (duration, intensity, repetitions, etc.) of each movement. Exxentric kBox4 will be adapted with special harnesses, insurances on the wall and in front of support bars, according to the needs of the patients. In addition to the major muscle groups, specific attention will be given to the key muscles involved in the gait cycle, such as the tibialis anterior, medial gastrocnemius, rectus femoris, and hamstrings, from a biomechanical perspective.
Physical activity: BPT combined with functional exercises
EXPERIMENTALIn addition to the BPT program (which includes the transverse focus on strength and resistance exercises), this intervention group will incorporate functional exercises that involve dual task training. The dual task training can encompass both motor-motor and motor-cognitive activities. This means that coordinated exercises will be performed, with cognitive activities introduced at the extremes of the movement. This approach ensures engagement of both physical and cognitive abilities during the PA sessions.
Control
ACTIVE COMPARATORParticipants in the control group will maintain their regular daily routines throughout the study period.
Interventions
This physical activity program will be based only on the work of basic physical training, in which specifically and mainly the strength and resistance will be worked, but also flexibility
Eligibility Criteria
You may qualify if:
- Patients with a medical diagnosis of idiopathic PD, Hoehn and Yahr scale stages of I-III.
- Patients who score ≥26 on the Montreal Cognitive Assessment (MoCA).
- Patients who have signed the IC.
- Patients with stable medication.
- Age between 50 and 70 years, and able to walk independently for 6 minutes.
You may not qualify if:
- Patients with a pathology other than idiopathic PD.
- Patients with cognitive impairment (MoCA \<26 points).
- Patients with uncontrolled cardiovascular disease, visual impairment, or recent musculoskeletal disorders in the extremities.
- Patients who are performing another therapeutic exercise protocol.
- Patients who have undergone surgery to influence any symptom from the PD.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Ramon Llulllead
- University of Coimbracollaborator
- Hospital Vall d'Hebroncollaborator
Study Sites (1)
Vall Hebron Institut de Recerca
Barcelona, Catalonia, 08031, Spain
Related Publications (3)
Magana JC, Deus CM, Gine-Garriga M, Montane J, Pereira SP. Exercise-Boosted Mitochondrial Remodeling in Parkinson's Disease. Biomedicines. 2022 Dec 12;10(12):3228. doi: 10.3390/biomedicines10123228.
PMID: 36551984BACKGROUNDDeus CM, Pereira SP, Cunha-Oliveira T, Pereira FB, Raimundo N, Oliveira PJ. Mitochondrial remodeling in human skin fibroblasts from sporadic male Parkinson's disease patients uncovers metabolic and mitochondrial bioenergetic defects. Biochim Biophys Acta Mol Basis Dis. 2020 Mar 1;1866(3):165615. doi: 10.1016/j.bbadis.2019.165615. Epub 2019 Nov 20.
PMID: 31759069BACKGROUNDMagana JC, Deus CM, Baldellou L, Avellanet M, Gea-Rodriguez E, Enriquez-Calzada S, Laguna A, Martinez-Vicente M, Hernandez-Vara J, Gine-Garriga M, Pereira SP, Montane J. Investigating the impact of physical activity on mitochondrial function in Parkinson's disease (PARKEX): Study protocol for A randomized controlled clinical trial. PLoS One. 2023 Nov 22;18(11):e0293774. doi: 10.1371/journal.pone.0293774. eCollection 2023.
PMID: 37992028DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Joel Montane, PhD
Universitat Ramon Llull
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 12, 2023
First Posted
July 27, 2023
Study Start
September 1, 2023
Primary Completion
May 31, 2024
Study Completion
April 1, 2026
Last Updated
February 25, 2025
Record last verified: 2025-01
Data Sharing
- IPD Sharing
- Will not share